Shares of Actavis Inc. rose Thursday after reports surfaced that one of the world’s biggest generic drugmaker has drawn interest from some competitors considering an acquisition.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.